Researchers examined Embase, Medline and Global Health databases from Jan. 1, 2008 to March 8 to assess the prevalence of norovirus in people with acute gastroenteritis. Of the examined cases, nearly one fifth — 18 percent — of patients had norovirus present.
Norovirus tended to be present in community and outpatient acute gastroenteritis cases (24 percent and 20 percent, respectively) compared to inpatient settings (17 percent).
“Targeted intervention to reduce norovirus burden, such as vaccines, should be considered,” the researchers concluded.
More Articles on Infection Control:
Synthetic Biologics Forms Clinical Advisory Board for C. Diff Prevention Product
Improving Sepsis Outcomes Using the EMR
Top 10 Infection Control Stories for June
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
